Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BCAXBicara Therapeutics Inc.

Nasdaq · CIK 0002023658
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts186

Identity from submissions API

NameBicara Therapeutics Inc.
CIK0002023658
TickersBCAX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-468-4219
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
116 HUNTINGTON AVENUE SUITE 703
BOSTON
MA
02116
MA
Mailing address
116 HUNTINGTON AVENUE SUITE 703
BOSTON
MA
02116
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

266 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 S-8 S-8 0001628280-26-072374 333-299940 261537301 33 207471 1 1
2026-11-09 10-Q 10-Q 0001628280-26-072169 001-42271 261536020 34 7819939 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001628280-26-071886 001-42271 261533849 34 402617 1 1
2026-10-21 144 xsl144X01/primary_doc.xml 0001950047-26-010350 001-42271 261476287 33 4643
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000635 005-94620 261446720 34 7665
2026-09-10 4 FORM 4 0001470831-26-000883 10944
2026-09-08 144 xsl144X01/primary_doc.xml 0001969223-26-001009 001-42271 261365080 33 5533
2026-09-08 144 xsl144X01/primary_doc.xml 0001969223-26-001008 001-42271 261365064 33 6214
2026-08-25 8-K 8-K 1.01,9.01 0001628280-26-058937 001-42271 261316627 34 319379 1 1
2026-08-14 4 FORM 4 0001470831-26-000819 5598
2026-08-14 3 FORM 3 0001470831-26-000818 419124
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000198 005-94620 261271723 34 12969
2026-08-12 4 FORM 4 0001470831-26-000814 9027
2026-08-12 4 FORM 4 0001470831-26-000813 9037
2026-08-12 4 FORM 4 0001470831-26-000812 9009
2026-08-11 S-8 S-8 0001628280-26-055779 333-298235 261264145 33 209506 1 1
2026-08-11 10-Q 10-Q 0001628280-26-055765 001-42271 261264056 34 16653140 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001628280-26-055500 001-42271 261260635 34 389065 1 1
2026-08-10 144 xsl144X01/primary_doc.xml 0001969223-26-000873 001-42271 261258686 33 5532
2026-08-10 144 xsl144X01/primary_doc.xml 0001969223-26-000872 001-42271 261258656 33 6214
2026-08-10 144 xsl144X01/primary_doc.xml 0001969223-26-000869 001-42271 261258476 33 5623
2026-07-29 4 FORM 4 0001470831-26-000738 5530
2026-07-29 4 FORM 4 0001470831-26-000737 5518
2026-07-29 3 FORM 3 0001470831-26-000736 427700
2026-07-29 3 FORM 3 0001470831-26-000735 428034
2026-07-28 8-K 8-K 5.02,7.01,9.01 0001628280-26-049937 001-42271 261207628 34 317489 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002268 005-94620 261206140 34 10924
2026-07-14 4 FORM 4 0001470831-26-000714 10437
2026-07-10 4 FORM 4 0001470831-26-000701 14247
2026-07-10 4 FORM 4 0001470831-26-000700 15129
2026-07-10 144 xsl144X01/primary_doc.xml 0001969223-26-000775 001-42271 261168751 33 5623
2026-07-08 144 xsl144X01/primary_doc.xml 0001950047-26-006962 001-42271 261162707 33 6734
2026-07-08 144 xsl144X01/primary_doc.xml 0001969223-26-000773 001-42271 261162508 33 6153
2026-07-08 144 xsl144X01/primary_doc.xml 0001969223-26-000771 001-42271 261162440 33 6047
2026-07-07 144 xsl144X01/primary_doc.xml 0001950047-26-006915 001-42271 261159417 33 5360
2026-06-25 144 xsl144X01/primary_doc.xml 0001950047-26-006490 001-42271 261121957 33 6036
2026-06-10 4 xslF345X06/form4-06102026_080603.xml 0001231919-26-000618 14303
2026-06-10 4 FORM 4 0001628280-26-042255 5498
2026-06-10 4 FORM 4 0001628280-26-042253 5533
2026-06-10 4 FORM 4 0001628280-26-042251 5543
2026-06-10 4 FORM 4 0001628280-26-042249 5561
2026-06-10 4 FORM 4 0001628280-26-042248 5490
2026-06-10 4 FORM 4 0001628280-26-042247 6221
2026-06-10 8-K 8-K 5.07 0001628280-26-042176 001-42271 261079652 34 158420 1 1
2026-06-01 144 xsl144X01/primary_doc.xml 0001883986-26-000002 001-42271 261050447 33 4240
2026-05-26 4 FORM 4 0001628280-26-038248 9024
2026-05-26 144 xsl144X01/primary_doc.xml 0001969223-26-000594 001-42271 261019620 33 6720
2026-05-21 8-K 8-K 8.01,9.01 0001628280-26-037377 001-42271 261009713 34 330102 1 1
2026-05-21 144 xsl144X01/primary_doc.xml 0001969223-26-000585 001-42271 261008254 33 6707
2026-05-20 4 FORM 4 0001628280-26-036885 10961
2026-05-18 4 FORM 4 0001628280-26-035937 10472
2026-05-18 144 xsl144X01/primary_doc.xml 0001969223-26-000564 001-42271 26993611 33 9186
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002552 005-94620 26989618 34 10816
2026-05-15 144 xsl144X01/primary_doc.xml 0001969223-26-000560 001-42271 26987592 33 7338
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000128 005-94620 26984384 34 11969
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002025 005-94620 26982623 34 11372
2026-05-12 4 FORM 4 0001628280-26-034087 5501
2026-05-12 3 FORM 3 0001628280-26-034079 402813
2026-05-11 10-Q 10-Q 0001628280-26-033429 001-42271 26963064 34 8254371 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001628280-26-033135 001-42271 26960885 34 258706 1 1
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001995961-26-000002 005-94620 26960571 34 11978
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001100 005-94620 26946578 34 10988
2026-04-28 4 FORM 4 0001628280-26-028054 9023
2026-04-27 144 xsl144X01/primary_doc.xml 0001969223-26-000470 001-42271 26900988 33 6128
2026-04-27 ARS ARS 0001628280-26-027322 001-42271 26896551 34 52352478
2026-04-27 DEFA14A DEFA14A 0001628280-26-027321 001-42271 26896548 34 1179988
2026-04-27 DEF 14A DEF 14A 0001628280-26-027320 001-42271 26896542 34 2360840 1 1
2026-04-22 4 FORM 4 0001628280-26-026604 9022
2026-04-21 144 xsl144X01/primary_doc.xml 0001969223-26-000461 001-42271 26879501 33 6705
2026-04-20 4 FORM 4 0001628280-26-026089 19828
2026-04-20 144 xsl144X01/primary_doc.xml 0001969223-26-000457 001-42271 26875016 33 8591
2026-04-17 4 FORM 4 0001628280-26-025817 10473
2026-04-15 144 xsl144X01/primary_doc.xml 0001969223-26-000449 001-42271 26864190 33 7927
2026-04-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000342 005-94620 26847848 34 7553
2026-03-31 S-8 S-8 0001628280-26-022098 333-294748 26814820 33 256878 1 1
2026-03-30 10-K 10-K 0001628280-26-022010 001-42271 26813089 34 8903186 1 1
2026-03-30 8-K 8-K 2.02,9.01 0001628280-26-021868 001-42271 26810003 34 272175 1 1
2026-03-26 4 FORM 4 0001628280-26-021543 9023
2026-03-25 144 xsl144X01/primary_doc.xml 0001969223-26-000395 001-42271 26792377 33 5537
2026-03-24 4 FORM 4 0001628280-26-020876 9022
2026-03-23 144 xsl144X01/primary_doc.xml 0001969223-26-000383 001-42271 26782168 33 6116
2026-03-20 4 FORM 4 0001628280-26-020236 19705
2026-03-20 144 xsl144X01/primary_doc.xml 0001969223-26-000379 001-42271 26778318 33 7995
2026-03-19 144 xsl144X01/primary_doc.xml 0001969223-26-000375 001-42271 26774602 33 7442
2026-03-18 144 xsl144X01/primary_doc.xml 0001969223-26-000370 001-42271 26769495 33 6808
2026-03-17 4 FORM 4 0001628280-26-018934 10335
2026-03-16 144 xsl144X01/primary_doc.xml 0001969223-26-000351 001-42271 26756532 33 7405
2026-03-11 4 FORM 4 0001628280-26-016874 8902
2026-03-09 144 xsl144X01/primary_doc.xml 0001969223-26-000319 001-42271 26734935 33 6152
2026-03-06 4 FORM 4 0001628280-26-015778 19640
2026-03-06 144 xsl144X01/primary_doc.xml 0001969223-26-000309 001-42271 26730757 33 5555
2026-03-05 4 FORM 4 0001628280-26-015423 10339
2026-03-05 4 FORM 4 0001628280-26-015421 17925
2026-03-05 4 FORM 4 0001628280-26-015419 13735
2026-03-05 144 xsl144X01/primary_doc.xml 0001969223-26-000297 001-42271 26726059 33 4961
2026-03-04 144 xsl144X01/primary_doc.xml 0001969223-26-000283 001-42271 26721928 33 6153
2026-03-04 144 xsl144X01/primary_doc.xml 0001969223-26-000282 001-42271 26721905 33 4367
2026-03-04 144 xsl144X01/primary_doc.xml 0001969223-26-000280 001-42271 26721637 33 4947
2026-03-03 144 xsl144X01/primary_doc.xml 0001969223-26-000275 001-42271 26715620 33 5529
2026-03-03 144 xsl144X01/primary_doc.xml 0001969223-26-000274 001-42271 26714197 33 4353
2026-03-03 144 xsl144X01/primary_doc.xml 0001969223-26-000272 001-42271 26714097 33 7380
2026-03-02 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-26-000066 005-94620 26708081 34 16518
2026-03-02 4 xslF345X05/form4-03022026_090351.xml 0001231919-26-000231 15927
2026-02-27 4 FORM 4 0001628280-26-012823 10334
2026-02-26 8-K 8-K 1.01,2.02,9.01 0001193125-26-076560 001-42271 26687857 34 490459 1 1
2026-02-26 424B5 424B5 0001193125-26-072875 333-290707 26681390 33 890809
2026-02-25 144 xsl144X01/primary_doc.xml 0001969223-26-000230 001-42271 26678368 33 6747
2026-02-25 FWP FWP 0001193125-26-068187 333-290707 26673981 34 69692
2026-02-24 424B5 424B5 0001193125-26-067160 333-290707 26672046 33 865329
2026-02-19 8-K 8-K 8.01,9.01 0001628280-26-009808 001-42271 26654966 34 316023 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001089 005-94620 26641257 34 10735
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-26-000288 005-94620 26637765 34 7338
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000689 005-94620 26626507 34 11165
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000365 005-94620 26601835 34 11350
2026-02-04 4 FORM 4 0001628280-26-005487 5392
2026-02-04 4 FORM 4 0001628280-26-005484 5402
2026-02-04 4 FORM 4 0001628280-26-005479 5392
2026-02-04 4 FORM 4 0001628280-26-005477 5390
2026-02-04 4 FORM 4 0001628280-26-005474 5363
2026-01-26 4 FORM 4 0001628280-26-003419 5213
2026-01-26 4 FORM 4 0001628280-26-003418 8885
2026-01-22 144 xsl144X01/primary_doc.xml 0001969223-26-000059 001-42271 26551634 33 6814
2026-01-22 144 xsl144X01/primary_doc.xml 0001969223-26-000056 001-42271 26551567 33 6115
2026-01-20 4 FORM 4 0001628280-26-002656 4694
2026-01-15 144 xsl144X01/primary_doc.xml 0001969223-26-000047 001-42271 26536260 33 6184
2026-01-12 8-K 8-K 8.01,9.01 0001628280-26-001766 001-42271 26524740 34 301683 1 1
2025-12-29 4 FORM 4 0001628280-25-059045 6929
2025-12-29 4 FORM 4 0001628280-25-059035 6966
2025-12-23 4 FORM 4 0002034668-25-000012 8887
2025-12-22 144 xsl144X01/primary_doc.xml 0001969223-25-001112 001-42271 251592492 33 7885
2025-12-18 4 FORM 4 0002034671-25-000012 6774
2025-12-16 4 FORM 4 0002034665-25-000011 10336
2025-12-15 144 xsl144X01/primary_doc.xml 0001969223-25-001093 001-42271 251571560 33 7295
2025-12-08 8-K 8-K 7.01,8.01,9.01 0002023658-25-000112 001-42271 251554618 34 4742586 1 1
2025-11-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003395 333-290707 251532225 33 1730
2025-11-26 424B5 424B5 0001193125-25-300510 333-290707 251530292 33 948997
2025-11-25 4 FORM 4 0002034668-25-000010 13739
2025-11-25 4 FORM 4 0002034665-25-000009 10334
2025-11-25 4 FORM 4 0002034671-25-000009 8904
2025-11-25 4 FORM 4 0002034679-25-000006 18887
2025-11-25 144 xsl144X01/primary_doc.xml 0001969223-25-000993 001-42271 251521700 33 5541
2025-11-24 144 xsl144X01/primary_doc.xml 0001969223-25-000987 001-42271 251513377 33 6234
2025-11-24 144 xsl144X01/primary_doc.xml 0001969223-25-000985 001-42271 251513095 33 7297
2025-11-24 144 xsl144X01/primary_doc.xml 0001969223-25-000984 001-42271 251513082 33 4950
2025-11-24 CORRESP filename1.htm 0001193125-25-293647 6889
2025-11-21 144 xsl144X01/primary_doc.xml 0001969223-25-000980 001-42271 251508475 33 6705
2025-11-21 144 xsl144X01/primary_doc.xml 0001969223-25-000979 001-42271 251508465 33 6734
2025-11-10 10-Q 10-Q 0002023658-25-000109 001-42271 251466626 34 7001465 1 1
2025-11-10 8-K 8-K 2.02,9.01 0002023658-25-000107 001-42271 251464353 34 262943 1 1
2025-10-20 4 FORM 4 0002034671-25-000006 8904
2025-10-16 4 FORM 4 0002034665-25-000006 10336
2025-10-16 144 xsl144X01/primary_doc.xml 0001969223-25-000854 001-42271 251397750 33 5663
2025-10-15 4 FORM 4 0002034671-25-000003 14278
2025-10-15 144 xsl144X01/primary_doc.xml 0001969223-25-000850 001-42271 251395054 33 6141
2025-10-15 144 xsl144X01/primary_doc.xml 0001969223-25-000849 001-42271 251395032 33 5005
2025-10-14 144 xsl144X01/primary_doc.xml 0001969223-25-000844 001-42271 251389990 33 4564
2025-10-10 4 FORM 4 0002034679-25-000003 8413
2025-10-10 4 FORM 4 0002034668-25-000007 8888
2025-10-09 144 xsl144X01/primary_doc.xml 0001969223-25-000841 001-42271 251385441 33 6119
2025-10-09 144 xsl144X01/primary_doc.xml 0001969223-25-000840 001-42271 251385187 33 4360
2025-10-08 4 FORM 4 0002034668-25-000004 19157
2025-10-08 4 FORM 4 0002034665-25-000004 17157
2025-10-08 144 xsl144X01/primary_doc.xml 0001969223-25-000838 001-42271 251382356 33 5530
2025-10-07 144 xsl144X01/primary_doc.xml 0001969223-25-000837 001-42271 251380082 33 4942
2025-10-07 144 xsl144X01/primary_doc.xml 0001969223-25-000836 001-42271 251379905 33 5575
2025-10-06 144 xsl144X01/primary_doc.xml 0001969223-25-000833 001-42271 251377234 33 4947
2025-10-06 144 xsl144X01/primary_doc.xml 0001969223-25-000831 001-42271 251376931 33 4351
2025-10-03 S-3 S-3 0001193125-25-230307 333-290707 251374444 33 1692585 1 1
2025-10-01 4 FORM 4 0001883986-25-000009 8385
2025-09-29 144 xsl144X01/primary_doc.xml 0001950047-25-007560 001-42271 251356709 33 5567
2025-09-17 4 FORM 4 0001883986-25-000006 11164
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003609 005-94620 251218244 34 10712
2025-08-12 10-Q 10-Q 0002023658-25-000098 001-42271 251206515 34 6007259 1 1
2025-08-12 8-K 8-K 2.02,9.01 0002023658-25-000094 001-42271 251204057 34 257660 1 1
2025-07-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002005369-25-000012 005-94620 251171176 34 18289
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001693 005-94620 251129424 34 11115
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001692 005-94620 251129418 34 11160
2025-06-18 4 FORM 4 0002023658-25-000085 11138
2025-06-16 144 xsl144X01/primary_doc.xml 0001950047-25-004373 001-42271 251050514 33 4961
2025-06-12 8-K 8-K 5.07 0002023658-25-000082 001-42271 251043341 34 155987 1 1
2025-06-10 4 FORM 4 0002023658-25-000079 5466
2025-06-10 4 xslF345X05/form4-06102025_080624.xml 0001415889-25-016483 13856
2025-06-10 4 FORM 4 0002023658-25-000078 5473
2025-06-10 4 FORM 4 0002023658-25-000077 5423
2025-06-10 4 FORM 4 0002023658-25-000076 5415
2025-06-10 4 FORM 4 0002023658-25-000075 5494
2025-06-10 4 FORM 4 0002023658-25-000074 6154
2025-06-10 4 FORM 4 0002023658-25-000073 5431
2025-06-06 8-K 8-K 1.01,9.01 0002023658-25-000063 001-42271 251031402 34 148467 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002396 005-94620 25953193 34 15155
2025-05-13 10-Q 10-Q 0002023658-25-000039 001-42271 25940219 34 5663418 1 1
2025-05-13 8-K 8-K 2.02,9.01 0002023658-25-000034 001-42271 25937174 34 254494 1 1
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001482 005-94620 25933187 34 11171
2025-04-25 ARS ARS 0002023658-25-000029 001-42271 25873731 34 30569723
2025-04-25 DEFA14A DEFA14A 0002023658-25-000028 001-42271 25873706 34 715599
2025-04-25 DEF 14A DEF 14A 0002023658-25-000027 001-42271 25873671 34 1629435 1 1
2025-03-28 S-8 S-8 0002023658-25-000015 333-286209 25781786 33 86560
2025-03-27 10-K 10-K 0002023658-25-000012 001-42271 25779567 34 15340915 1 1
2025-03-27 8-K 8-K 2.02,9.01 0002023658-25-000006 001-42271 25775338 34 271738 1 1
2025-03-18 4 4 0000950170-25-041546 13017
2025-03-14 144 xsl144X01/primary_doc.xml 0001950047-25-001862 001-42271 25740295 33 4790
2025-03-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000956 005-94620 25694469 34 11078
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000722 005-94620 25612349 34 11194
2025-01-13 8-K 8-K 7.01,9.01 0001193125-25-005002 001-42271 25524882 34 13133382 1 1
2024-11-12 10-Q 10-Q 0002023658-24-000002 001-42271 241447816 34 7935777 1 1
2024-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-24-255166 001-42271 241443373 34 3651021 1 1
2024-09-26 SC 13G SC 13G 0001193125-24-226971 005-94620 241329408 34 145665
2024-09-26 SC 13G SC 13G 0001104659-24-103150 005-94620 241329160 34 80074
2024-09-23 SC 13D SC 13D 0001104659-24-102048 005-94620 241316453 34 96777
2024-09-18 4 xslF345X05/form4-09182024_100931.xml 0001415889-24-023653 26602
2024-09-18 SC 13D SCHEDULE TO REPORT BENEFICIAL OWNERSHIP OF 5% OR MORE 0001999371-24-012103 005-94620 241308260 34 115202
2024-09-18 4 xslF345X05/ownership.xml 0001999371-24-012102 15923
2024-09-18 SC 13G filing.txt 0000315066-24-001989 005-94620 241306557 34 7719
2024-09-18 4 4 0000950170-24-107661 16960
2024-09-18 4 4 0000950170-24-107660 16344
2024-09-17 4 xslF345X05/e663893_4-bicara.xml 0001193805-24-001131 32331
2024-09-16 4 xslF345X05/form4-09162024_090949.xml 0001415889-24-023452 13837
2024-09-16 4 4 0000950170-24-106881 5197
2024-09-16 4 4 0000950170-24-106880 5990
2024-09-16 4 4 0000950170-24-106877 14079
2024-09-16 4 4 0000950170-24-106873 5248
2024-09-16 4 4 0000950170-24-106868 5276
2024-09-16 4 4 0000950170-24-106866 22941
2024-09-16 8-K 8-K 5.03,9.01 0001193125-24-219617 001-42271 241301260 34 172951
2024-09-13 SEC STAFF LETTER filename1.pdf 9999999997-24-003873 333-281722 64422
2024-09-13 S-8 S-8 0001193125-24-218929 333-282113 241298370 33 88200
2024-09-13 424B4 424B4 0001193125-24-218862 333-281722 241297880 33 6119057
2024-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-12 16:01:00 9999999995-24-002816 333-281722 241296371 33 1711
2024-09-12 3 xslF345X02/form3-09132024_010945.xml 0001415889-24-023340 16246
2024-09-12 3 3 0000950170-24-106167 17439
2024-09-12 3 3 0000950170-24-106162 21264
2024-09-12 3 3 0000950170-24-106161 26752
2024-09-12 3 3 0000950170-24-106159 18723
2024-09-12 3 3 0000950170-24-106158 23139
2024-09-12 3 3 0000950170-24-106154 27332
2024-09-12 3 3 0000950170-24-106153 18985
2024-09-12 3 3 0000950170-24-106152 26706
2024-09-12 3 3 0000950170-24-106150 26749
2024-09-12 3 xslF345X02/e663886_3-bicara.xml 0001193805-24-001113 24596
2024-09-12 3 3 0000950170-24-106147 20534
2024-09-12 3 3 0000950170-24-106145 17440
2024-09-12 3 3 0000950170-24-106144 9653
2024-09-12 3 3 0000950170-24-106143 18778
2024-09-12 3 3 0000950170-24-106142 19365
2024-09-12 3 3 0000950170-24-106141 8727
2024-09-12 3 3 0000950170-24-106139 9355
2024-09-12 3 FORM 3 0001999371-24-011857 12612
2024-09-12 S-1MEF S-1MEF 0001193125-24-218205 333-282078 241296119 33 64985
2024-09-12 CERT 8A_Cert_BCAX.pdf 0001354457-24-000676 001-42271 241294449 34 760941
2024-09-11 S-1/A S-1/A 0001193125-24-217265 333-281722 241292903 33 6237137
2024-09-10 8-A12B 8-A12B 0001193125-24-216612 001-42271 241290135 34 14084
2024-09-10 CORRESP filename1.htm 0001193125-24-216602 10342
2024-09-10 CORRESP filename1.htm 0001193125-24-216598 6315
2024-09-06 S-1/A S-1/A 0001193125-24-214674 333-281722 241282905 33 7963221
2024-09-03 CORRESP filename1.htm 0001193125-24-211540 34470
2024-09-03 S-1/A S-1/A 0001193125-24-211537 333-281722 241271909 33 6210546
2024-08-29 UPLOAD filename1.pdf 0000000000-24-009881 377-07267 46064
2024-08-27 CORRESP filename1.htm 0001193125-24-207857 109793
2024-08-22 CORRESP filename1.htm 0001193125-24-205396 22313
2024-08-22 S-1 S-1 0001193125-24-205393 333-281722 241232477 33 7583289
2024-08-06 UPLOAD filename1.pdf 0000000000-24-008954 377-07267 46261
2024-07-22 DRS/A filename1.htm 0000950123-24-006696 377-07267 241132220 33 5433332
2024-07-22 DRSLTR filename1.htm 0000950123-24-006695 79664
2024-07-08 SEC STAFF LETTER filename1.pdf 9999999997-24-003175 65293
2024-07-05 UPLOAD filename1.pdf 0000000000-24-007659 377-07267 62525
2024-06-10 DRS filename1.htm 0000950123-24-006172 377-07267 241033739 33 5650870

Latest XBRL company facts

One latest value per concept from companyfacts (186 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 66.39M 2026-11-03 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
dei EntityPublicFloat Entity Public Float USD 376.70M 2025-06-30 2025 FY 10-K 2026-03-30 0001628280-26-022010
ffd NetFeeAmt NetFeeAmt USD 185.42 2026-11-05 S-8 2026-11-10 0001628280-26-072374
ffd TtlFeeAmt TtlFeeAmt USD 185.42 2026-11-05 S-8 2026-11-10 0001628280-26-072374
ffd TtlOfferingAmt TtlOfferingAmt USD 2.13M 2026-11-05 S-8 2026-11-10 0001628280-26-072374
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-05 S-8 2026-11-10 0001628280-26-072374
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -608,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 12.88M 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.46M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 953.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.98M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 24.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap Assets Assets USD 460.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AssetsCurrent Assets, Current USD 451.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 438.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 362.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 360.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 82.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 414.80M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 82.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -14.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 66.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 66.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -185.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 217,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 217,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 360.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 360.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 1.37M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 98.30M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 52.04M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 191.60M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 187.40M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 10,000 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 8.28M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.08M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 97.78M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap Depreciation Depreciation USD 148,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.229 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.041 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 6.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 88.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 13.40M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 642,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 14.05M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2023-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 46.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -182.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap IncomeTaxesPaid Income Taxes Paid USD 155,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 31.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -28.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 59,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 712,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 95,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 165,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -830,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 13.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap InvestmentsAndCash Investments and Cash USD 442.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.79M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.19M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 604,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 84,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap Liabilities Liabilities USD 51.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 460.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap LiabilitiesCurrent Liabilities, Current USD 51.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap LongTermInvestments Long-term Investments USD 117.42M 2025-09-30 2025 Q3 10-Q 2025-11-10 0002023658-25-000109
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 360.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 168.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -45.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -137.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -182.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 13.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingExpenses Operating Expenses USD 195.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -195.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingLeaseCost Operating Lease, Cost USD 900,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2025-06-03 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.71M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 880,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 723,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 978,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.059 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 97.80M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 7.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1.30M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 29.80M 2024-09-01 2024-09-30 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 318.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 244.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 783,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 9.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 332.40M 2024-09-16 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 161.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 272.30M 2023-01-01 2023-12-31 2025 Q3 10-Q 2025-11-10 0002023658-25-000109
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 200.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 965,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap RegistrationPaymentArrangementMaximumPotentialConsideration Registration Payment Arrangement, Maximum Potential Consideration USD 400.00M 2025-10-03 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 92.10M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0002023658-25-000109
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -541.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 20.13M 2024-09-01 2024-09-30 2025 Q3 10-Q 2025-11-10 0002023658-25-000109
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 18 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap SecurityDepositLiability Security Deposit Liability USD 200,000 2026-08-21 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 24.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 5.45 2024-06-30 2025 Q2 10-Q 2025-08-12 0002023658-25-000098
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.908 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 42.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 8.49 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 19.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 546,308 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 15.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 8.24M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 80.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.96 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 90.40M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 12.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 12.96 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 19.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ShortTermInvestments Short-term Investments USD 318.12M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 409.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.108 2024-09-01 2024-09-30 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 367.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 161.76M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.21M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2022-04-26 2024 FY 10-K 2025-03-27 0002023658-25-000012
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2024-09-14 2024 Q3 10-Q 2024-11-12 0002023658-24-000002
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-09-14 2024 Q3 10-Q 2024-11-12 0002023658-24-000002
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 1.60M 2026-08-21 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 38.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022010
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 65.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 65.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001628280-26-072169

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →